{"protocol":{"protocol":"OPEN EVIDENCE GAP PROTOCOL v0.1","phase":"PHASE 1 — EXTERNAL CHALLENGE ACTIVATION","launched_at":"2026-10-05","phase_duration_days":30,"target_invitations":30,"acknowledgement_target":"<24 hours","initial_review_target":"<72 hours","login_required":false,"public_file_upload":false,"no_bounty":true,"no_leaderboard":true,"no_contributor_score":true,"no_auto_state_change":true,"rate_limit":"5 submissions per IP-derived key per rolling 10 minutes","attribution_disclaimer":"Public attribution means evidence contribution only. It does not imply endorsement of StructEvidence's final conclusion."},"count":6,"gaps":[{"gap_id":"OEG-CML-001","case_id":"CML-PDRE-001","case_title":"800V DC Data Center Power Architecture","case_url":"https://structurevidence.org/cases/800vdc/","claim_id":"CML-PDRE-001.INDEPENDENT_VALIDATION","claim_text":"Independent third-party validation of the reported 800VDC / SST deployment is established.","current_state":"NOT_ESTABLISHED","current_scope":"One operator-reported deployment at one named campus; no independent performance validation is established.","evidence_cutoff":"2026-09-20T10:46:47Z","what_is_established":["One named operator reported commercial operation of a materially relevant 10kV AC to SST to 800VDC architecture."],"what_is_not_established":["Independent verification of operating conditions, performance, availability, efficiency, or safety at the named site."],"what_would_change_this":"An independently attributable operating or test record tied to the named site, with observation period, conditions, method, and responsible organization.","acceptable_source_examples":["Independent engineering test report","Operator record with attributable methodology","Third-party commissioning or performance record"],"non_qualifying_examples":["Vendor marketing copy","Unattributed screenshots","A second retelling of the operator's original announcement"],"last_reviewed":"2026-10-05","challenge_url":"https://structevidence.com/gaps/OEG-CML-001/"},{"gap_id":"OEG-CML-002","case_id":"CML-PDRE-001","case_title":"800V DC Data Center Power Architecture","case_url":"https://structurevidence.org/cases/800vdc/","claim_id":"CML-PDRE-001.MULTI_ENTITY_REPLICATION","claim_text":"The 800VDC / SST architecture has been replicated by multiple independent entities.","current_state":"NOT_ESTABLISHED","current_scope":"The public record supports a single operator-reported instance, not replication across independent operators or sites.","evidence_cutoff":"2026-09-20T10:46:47Z","what_is_established":["A single named operator reported one materially relevant field deployment."],"what_is_not_established":["A second independently attributable deployment","Multi-operator replication","Repeat procurement or industry adoption"],"what_would_change_this":"A public record for another attributable operator or independently controlled site showing a materially comparable deployed architecture and operating status.","acceptable_source_examples":["Named operator commissioning record","Regulatory or grid-connection record","Independent case study identifying operator, site, architecture, and date"],"non_qualifying_examples":["Multiple articles about the same site","Planned projects without commissioning","Vendor pipeline totals without named deployments"],"last_reviewed":"2026-10-05","challenge_url":"https://structevidence.com/gaps/OEG-CML-002/"},{"gap_id":"OEG-BESS-001","case_id":"SE-BESS-SODIUM-001","case_title":"Sodium-Ion BESS Commercialization","case_url":"https://structurevidence.org/cases/sodium-ion-bess/","claim_id":"SE-BESS-SODIUM-001.NAMED_COMMISSIONED_SITE","claim_text":"A named customer sodium-ion stationary BESS site has been commissioned.","current_state":"NOT_ESTABLISHED","current_scope":"Stationary sodium-ion BESS only; vehicle, starter-battery, and solid-state battery claims are excluded.","evidence_cutoff":"2026-09-24","what_is_established":["A stationary sodium-ion BESS product launch","A public supply cooperation agreement","Future delivery milestones stated by manufacturers"],"what_is_not_established":["Completed customer delivery","Named-site commissioning or grid connection","Customer acceptance"],"what_would_change_this":"A public, attributable record identifying the customer or operator, site, sodium-ion stationary system, commissioning or grid-connection date, and operational status.","acceptable_source_examples":["Customer acceptance record","Named-site commissioning notice","Grid-connection or regulator record tied to the system"],"non_qualifying_examples":["Product launch","Framework agreement","Future delivery target","Unnamed pilot or showcase"],"last_reviewed":"2026-10-05","challenge_url":"https://structevidence.com/gaps/OEG-BESS-001/"},{"gap_id":"OEG-BESS-002","case_id":"SE-BESS-SODIUM-001","case_title":"Sodium-Ion BESS Commercialization","case_url":"https://structurevidence.org/cases/sodium-ion-bess/","claim_id":"SE-BESS-SODIUM-001.INDEPENDENT_FIELD_PERFORMANCE","claim_text":"Independent field-performance evidence for sodium-ion stationary BESS is established.","current_state":"NOT_ESTABLISHED","current_scope":"Public evidence reviewed for stationary sodium-ion BESS; manufacturer-attributed product claims are not independent field-performance evidence.","evidence_cutoff":"2026-09-24","what_is_established":["The product was publicly launched and showcased","Manufacturer-attributed performance and field-validation language exists"],"what_is_not_established":["Independent field measurements","Attributable operating duration and conditions","Independent safety or performance validation"],"what_would_change_this":"Attributable independent field-operation or performance evidence collected after commissioning at a named stationary sodium-ion BESS. It should identify the responsible operator or third party, site and system, commissioning status, observation period, operating conditions, and method. Evidence may report one or more relevant measures—such as operating duration, availability, delivered capacity or energy, degradation, cycle history, or reliability; all measures are not required at once.","acceptable_source_examples":["Independent post-commissioning field report with attributable methods","Operator record reporting operating duration, availability, delivered capacity or energy, degradation, cycle history, or reliability","Regulator or research-institute field evaluation tied to a named commissioned system"],"non_qualifying_examples":["Manufacturer brochure or generic product specification","Lab-only test or simulation","Planned deployment","Shipment without commissioning","Unattributed performance chart"],"last_reviewed":"2026-10-05","challenge_url":"https://structevidence.com/gaps/OEG-BESS-002/"},{"gap_id":"OEG-ONC-001","case_id":"SE-ONC-NSQNSCLC-CN-001","case_title":"China Non-Squamous NSCLC Evidence Pathway","case_url":"https://structurevidence.org/cases/nsq-nsclc-china/","claim_id":"SE-ONC-NSQNSCLC-CN-001.HOSPITAL_AGGREGATE_OUTCOME_DATA","claim_text":"A hospital-specific aggregate outcome dataset has been acquired for this public NSCLC case.","current_state":"NOT_ESTABLISHED","current_scope":"China non-squamous NSCLC; the detailed index cohort is EGFR-mutated locally advanced or metastatic disease after EGFR-TKI progression.","evidence_cutoff":"2026-09-28","what_is_established":["Public regulatory, randomized-trial, guideline, surgical-cohort, ECMO-context, and transplant-consensus sources were identified within their stated scopes."],"what_is_not_established":["An authorized hospital-specific aggregate dataset for the index cohort","Hospital-level exposure, follow-up, survival, adverse-event, or patient-feedback outcomes for this case"],"what_would_change_this":"A lawful public aggregate dataset or citable public analysis with a defined hospital population, cohort criteria, treatment exposure, outcome definitions, follow-up, censoring, and permitted reuse boundary.","acceptable_source_examples":["Peer-reviewed hospital aggregate study","Public registry analysis with cohort and censoring definitions","Authorized de-identified aggregate report with reuse terms"],"non_qualifying_examples":["Patient-identifiable data","Anecdotes","Hospital marketing claims","Aggregate numbers without cohort or outcome definitions"],"last_reviewed":"2026-10-05","challenge_url":"https://structevidence.com/gaps/OEG-ONC-001/"},{"gap_id":"OEG-ONC-002","case_id":"SE-ONC-NSQNSCLC-CN-001","case_title":"China Non-Squamous NSCLC Evidence Pathway","case_url":"https://structurevidence.org/cases/nsq-nsclc-china/","claim_id":"SE-ONC-NSQNSCLC-CN-001.IVONESCIMAB_APPROVAL","claim_text":"Ivonescimab with pemetrexed and carboplatin was approved in China for the defined post-EGFR-TKI non-squamous NSCLC indication.","current_state":"SUPPORTED","current_scope":"Population-level regulatory status in China for EGFR-mutated locally advanced or metastatic non-squamous NSCLC progressing after EGFR-TKI; other populations, treatment lines, combinations, and jurisdictions are outside this claim.","evidence_cutoff":"2026-09-28","what_is_established":["An official NMPA public record supports approval of ivonescimab with pemetrexed and carboplatin for the defined China indication."],"what_is_not_established":["Approval for populations, treatment lines, combinations, or jurisdictions outside the regulator-defined scope","Comparative superiority or outcome claims beyond the cited evidence"],"what_would_change_this":"An official regulator record that changes, narrows, expands, suspends, withdraws, or corrects the approval status, label, combination, population, or treatment-line scope; or an authoritative correction or retraction of the cited regulatory source.","acceptable_source_examples":["NMPA approval label or official indication update","Official regulator safety, suspension, withdrawal, or correction notice","Authoritative source correction tied to the cited approval"],"non_qualifying_examples":["Manufacturer commercial copy","Media summary without a regulator record","Trial result alone without a regulatory action","Approval in another jurisdiction","Unverified drug database entry"],"last_reviewed":"2026-10-05","challenge_url":"https://structevidence.com/gaps/OEG-ONC-002/"}]}